Manufactured by Enzymotec (Migdal HaEmek, Israel), the ingredient is clinically proven to provide cardiovascular benefits.
Omega-Sterols, a patented ingredient comprising “naturally occurring hybrids of phytosterols and omega-3,” has garnered an Australian patent (No. AU-0552025002). Manufactured by Enzymotec (Migdal HaEmek, Israel), the ingredient is clinically proven to provide cardiovascular benefits, including for blood lipid control and support of health levels of blood triglycerides and LDL cholesterol.
The Australian patent addresses Omega-Sterols’ benefits as a functional food for diabetics. Enzymotec says the patent is part of five different patents that cover the ingredient’s properties, composition, and methods of use.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.